DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Revlimid (Lenalidomide) - News

 
 



News related to Revlimid (Lenalidomide) and/or conditions it is approved for

Study supports evidence that Rab disruption may be effective strategy for treating multiple myeloma
Source: Cancer / Oncology News From Medical News Today [2016.04.22]
Roswell Park Cancer Institute (RPCI) researchers are investigating agents that target and disrupt the trafficking of monoclonal antibodies in multiple myeloma, a cancer of the bone marrow.

Identification of therapeutic targets in multiple myeloma
Source: Cancer / Oncology News From Medical News Today [2016.04.22]
Multiple myeloma (MM) is a hematological cancer that frequently acquires resistance to chemotherapeutic drugs.

Multiple Myeloma
Source: MedicineNet Amyloidosis Specialty [2016.04.01]
Title: Multiple Myeloma
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 4/1/2016 12:00:00 AM

Empliciti Approved for Multiple Myeloma
Source: MedicineNet Multiple Myeloma Specialty [2015.12.01]
Title: Empliciti Approved for Multiple Myeloma
Category: Health News
Created: 11/30/2015 12:00:00 AM
Last Editorial Review: 12/1/2015 12:00:00 AM

Ninlaro Approved for Multiple Myeloma
Source: MedicineNet Multiple Myeloma Specialty [2015.11.23]
Title: Ninlaro Approved for Multiple Myeloma
Category: Health News
Created: 11/20/2015 12:00:00 AM
Last Editorial Review: 11/23/2015 12:00:00 AM

Darzalex Approved for Multiple Myeloma
Source: MedicineNet Multiple Myeloma Specialty [2015.11.17]
Title: Darzalex Approved for Multiple Myeloma
Category: Health News
Created: 11/16/2015 12:00:00 AM
Last Editorial Review: 11/17/2015 12:00:00 AM

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015